Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Inappropriate schedule of product administration, Overdose, Weight decreased
Clinical narrative: hyperthyroidism; irregular heartbeats; can't eat; constant GI issues; weigh less than 100 pounds because I am so sick all the time; weigh less than 100 pounds because I am so sick all the time; first dose received on 01May2021 at 06:30/Second dose received on 01May2021; first dose received on 01May2021 at 06:30/Second dose received on 01May2021; This is a spontaneous report from a contactable Other HCP. This 34-year-old female Other HCP (patient) reported for self. A 34-years-old (non-pregnant) female patient received first dose of bnt162b2 (COMIRNATY, solution for injection, Lot Number: EW6179 and Expiry date was not reported) dose 1 via an unspecified route of administration in arm right on 01May2021 at 06:30 (age at vaccination was 34-years-old) as dose 1, single and dose 2 via an unspecified route of administration in arm right on 01May2021 (Lot Number: EW0186 and Expiry date was not reported) as dose 2, single dose for COVID-19 immunisation. The patient was not pregnant at time of vaccination. The patient had known allergies with Zoloft. Medical history included arthritis in low back and neck from an unknown date and unknown if ongoing, covid-19 from an unknown date and unknown if ongoing. The patient had COVID prior vaccination and had not COVID tested post vaccination. Concomitant medications included in two weeks was paracetamol (TYLENOL), xylometazoline hydrochloride (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccines in four weeks. The patient previously took zoloft and experienced drug hypersensitivity. First dose received on 01May2021 at 06:30 / Second dose received on 01May2021. The patient reported, since receiving her vaccination, on 29May2021, she has been diagnosed with hyperthyroidism, she has been having irregular heartbeats, can't eat, constant GI issues, and now weigh less than 100 pounds because she was so sick all the time. The patient has been to the Emergency Room since, her primary doctor, and now the endocrinologist. AE resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included heart rate: irregular on 29May2021. Treatment received for the events. For AE treatment they are still trying to figure it out. Outcome of the events was not recovered.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the event hyperthyroidism cannot be excluded   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate